Expertise in
15
conditions

Dr. Marilyn S. Huang

Obstetrics and Gynecology
UVA Health General Gynecology
1221 Lee St Fl 3, 
Charlottesville, VA 
Accepting New Patients
Offers Telehealth
Expertise in
15
conditions
UVA Health General Gynecology
1221 Lee St Fl 3, 
Charlottesville, VA 

Overview

Marilyn Huang is an Obstetrics and Gynecologist practicing medicine in Charlottesville, Virginia.

Dr. Huang is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, and Hysterectomy.

She is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 13 clinical trials. Dr. Huang is currently accepting new patients.

Specialties

Obstetrics and Gynecology

Licenses

Obstetrics & Gynecology in VA

Hospital Affiliations

University Of Virginia Medical Center
Nyu Langone Hospitals

Languages Spoken

English
Mandarin

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

UVA Health General Gynecology
1221 Lee St Fl 3, Charlottesville, VA 22903
Other Locations
UVA Health Gynecologic Oncology
1240 Lee St Fl 2, Charlottesville, VA 22908

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Phase 1/2, Open-Label, Multi-Arm Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN1884 in Combination With AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors
A Phase 1/2, Open-Label, Multi-Arm Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN1884 in Combination With AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors
Enrollment Status: Completed
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 1/Phase 2
A Phase 0 Window-of-Opportunity Pharmacodynamic Trial of Triapine (NSC# 663249) in Uterine Corpus Serous Adenocarcinoma
A Phase 0 Window-of-Opportunity Pharmacodynamic Trial of Triapine (NSC# 663249) in Uterine Corpus Serous Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Procedure, Drug
Study Drug: Triapine
Study Phase: Early Phase 1
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 09, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Letrozole
Study Phase: Phase 2
A Phase 1 Study of SGN-STNV in Advanced Solid Tumors
A Phase 1 Study of SGN-STNV in Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drug: SGN-STNV
Study Phase: Phase 1
Phase II Single Arm Study of Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
Phase II Single Arm Study of Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
Enrollment Status: Terminated
Publish Date: June 18, 2024
Intervention Type: Drug
Study Drugs: Pembrolizumab, Paclitaxel, Cisplatin, Carboplatin, Bevacizumab
Study Phase: Phase 2
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Enrollment Status: Unknown
Publish Date: May 03, 2024
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma
A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma
Enrollment Status: Unknown
Publish Date: November 08, 2023
Intervention Type: Drug
Study Drugs: AL3818, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Carboplatin
Study Phase: Phase 3
Phase II Single Arm Study of Combination Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Ovarian, Fallopian Tube, or Peritoneal Carcinoma Receiving Neoadjuvant Chemotherapy
Phase II Single Arm Study of Combination Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Ovarian, Fallopian Tube, or Peritoneal Carcinoma Receiving Neoadjuvant Chemotherapy
Enrollment Status: Terminated
Publish Date: November 07, 2023
Intervention Type: Drug
Study Drugs: Pembrolizumab, Paclitaxel, Carboplatin
Study Phase: Phase 2
View 9 Less Clinical Trials

84 Total Publications

Oncology Clinicians' Attitudes on Hormonal Therapy After Chemoradiotherapy for Cervical Cancer.
Oncology Clinicians' Attitudes on Hormonal Therapy After Chemoradiotherapy for Cervical Cancer.
Journal: JAMA network open
Published: April 14, 2026
Similar Doctors
Expertise in
35
conditions
Dr. Jo V. Pinkerton
Obstetrics and Gynecology
Expertise in
35
conditions
Dr. Jo V. Pinkerton
Obstetrics and Gynecology
Referral may be required

UVA Health Midlife Health And Gynecologic Specialties Northridge

2955 Ivy Rd Ste 104, 
Charlottesville, VA 
 (0.1 miles away)
434-243-4720
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jo Pinkerton is an Obstetrics and Gynecologist practicing medicine in Charlottesville, Virginia. Dr. Pinkerton is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses Menopause, Postmenopausal Osteoporosis, Premature Ovarian Failure, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Pinkerton is currently accepting new patients.

Expertise in
15
conditions
Dr. Linda R. Duska
Obstetrics and Gynecology
Expertise in
15
conditions
Dr. Linda R. Duska
Obstetrics and Gynecology
Referral may be required

UVA Health General Gynecology

1221 Lee St Fl 3, 
Charlottesville, VA 
 (0.1 miles away)
434-924-1955
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Linda Duska is an Obstetrics and Gynecologist practicing medicine in Charlottesville, Virginia. Dr. Duska is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Salpingo-Oophorectomy. Dr. Duska is currently accepting new patients.

Expertise in
16
conditions
Dr. Paola A. Gehrig
Obstetrics and Gynecology
Expertise in
16
conditions
Dr. Paola A. Gehrig
Obstetrics and Gynecology
Referral may be required

UVA Health Gynecologic Oncology

1240 Lee St Fl 2, 
Charlottesville, VA 
 (6.6 miles away)
434-924-5100
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Paola Gehrig is an Obstetrics and Gynecologist practicing medicine in Charlottesville, Virginia. Dr. Gehrig is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Hysterectomy, and Vaginectomy. Dr. Gehrig is currently accepting new patients.

Frequently Asked Questions about Dr. Marilyn S. Huang

How do I make an appointment with Dr. Marilyn S. Huang?

You can book an appointment with Dr. Marilyn S. Huang by calling their office at 434-924-1955. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marilyn S. Huang a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marilyn S. Huang is classified as an Elite expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marilyn S. Huang specialize in?

While Dr. Marilyn S. Huang is a Obstetrics and Gynecology, they have specific expertise in Cervical Cancer, Ovarian Cancer, and Endometrial Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Marilyn S. Huang participate in research or clinical trials?

Yes. Dr. Marilyn S. Huang has published 84 articles and abstracts on conditions like Cervical Cancer. You can view a list of Dr. Marilyn S. Huang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marilyn S. Huang accept my insurance?

Dr. Marilyn S. Huang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 434-924-1955 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Huang's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 7 Advanced Conditions
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile